Company intelligence / Profile preview
Leaderna Therapeutics
Chinaleaderna.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Leaderna Therapeutics is a spin-off from HitGen Inc., focused on developing advanced RNA therapies. Its lead asset Lipisense® targets ANGPTL4 to treat lipid metabolism disorders and has reached Phase II trials for hypertriglyceridemia. The company has partnered with Lipigon Pharmaceuticals to develop and commercialize Lipisense® in Greater China, with promising early clinical results and significant deal value ($91 million). Another pipeline program targets AGT for essential hypertension.
- Therapeutic areas
- Metabolic DisordersCardiovascularEndocrinology
- Modalities
- Antisense oligonucleotides (ASO)Oligonucleotide therapiesRNA-based drugs
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Lipigon Pharmaceuticals AB – development/commercialization partnership for Lipisense®, covering Greater China region; deal valued up to $91 million USD.
Beyond the preview
Go deeper on Leaderna Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leaderna Therapeutics.